|
QKI expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.838100E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.68300000003008E-06 |
| Normal-vs-Stage2 |
9.845700E-02 |
| Normal-vs-Stage3 |
2.711600E-01 |
| Normal-vs-Stage4 |
9.782000E-01 |
| Stage1-vs-Stage2 |
8.304000E-02 |
| Stage1-vs-Stage3 |
3.066300E-02 |
| Stage1-vs-Stage4 |
2.234600E-01 |
| Stage2-vs-Stage3 |
8.254400E-01 |
| Stage2-vs-Stage4 |
5.797600E-01 |
| Stage3-vs-Stage4 |
6.526600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.574730E-04 |
| Normal-vs-AfricanAmerican |
3.057600E-02 |
| Normal-vs-Asian |
1.135610E-02 |
| Caucasian-vs-AfricanAmerican |
4.761400E-01 |
| Caucasian-vs-Asian |
5.955400E-01 |
| AfricanAmerican-vs-Asian |
4.989600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.53020000000148E-05 |
| Normal-vs-Female |
2.095800E-01 |
| Male-vs-Female |
3.224400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.481050E-03 |
| Normal-vs-Extreme_Weight |
1.53780000000658E-06 |
| Normal-vs-Obese |
3.600000E-01 |
| Normal-vs-Extreme_Obese |
2.177800E-04 |
| Normal_Weight-vs-Extreme_Weight |
4.964000E-01 |
| Normal_Weight-vs-Obese |
6.760000E-02 |
| Normal_Weight-vs-Extreme_Obese |
3.744200E-01 |
| Extreme_Weight-vs-Obese |
4.956100E-03 |
| Extreme_Weight-vs-Extreme_Obese |
5.310600E-01 |
| Obese-vs-Extreme_Obese |
1.330180E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.561000E-01 |
| Normal-vs-Age(41-60Yrs) |
6.472200E-02 |
| Normal-vs-Age(61-80Yrs) |
2.15969999994847E-06 |
| Normal-vs-Age(81-100Yrs) |
4.769700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.873800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.426300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.450810E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.397900E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.180360E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.049200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.598600E-04 |
| Normal-VS-Type2 PRCC |
1.559850E-04 |
| Normal-VS-KIRP CIMP |
7.714000E-01 |
| Normal-VS-Unclassified PRCC |
5.040400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.659800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.373800E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.361800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.043500E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.157400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.423000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.37180000000259E-05 |
| Normal-vs-N1 |
6.267600E-01 |
| Normal-vs-N2 |
1.480320E-02 |
| N0-vs-N1 |
1.353610E-02 |
| N0-vs-N2 |
8.777200E-01 |
| N1-vs-N2 |
9.823600E-03 |
|
|
